larotrectinib
bayer
['larotrectinib']
larotrectinib shows continued tumor-agnostic efficacy in pediatric trk fusion+ cancer #asco22 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.